Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Inogen (INGN) Common Equity (2016 - 2022)

Inogen (INGN) has disclosed Common Equity for 11 consecutive years, with $350.8 million as the latest value for Q3 2022.

  • On a quarterly basis, Common Equity fell 10.25% to $350.8 million in Q3 2022 year-over-year; TTM through Sep 2022 was $350.8 million, a 10.25% decrease, with the full-year FY2021 number at $370.2 million, up 5.89% from a year prior.
  • Common Equity was $350.8 million for Q3 2022 at Inogen, down from $356.5 million in the prior quarter.
  • In the past five years, Common Equity ranged from a high of $390.9 million in Q3 2021 to a low of $246.3 million in Q1 2018.
  • A 5-year average of $337.5 million and a median of $349.6 million in 2020 define the central range for Common Equity.
  • Peak YoY movement for Common Equity: soared 36.73% in 2018, then fell 10.25% in 2022.
  • Inogen's Common Equity stood at $310.4 million in 2018, then rose by 11.02% to $344.6 million in 2019, then increased by 1.45% to $349.6 million in 2020, then rose by 5.89% to $370.2 million in 2021, then fell by 5.24% to $350.8 million in 2022.
  • Per Business Quant, the three most recent readings for INGN's Common Equity are $350.8 million (Q3 2022), $356.5 million (Q2 2022), and $358.3 million (Q1 2022).